TABLE 4.
1st Baerveldt Surgery (n=76) | All Baerveldt Surgeries (n=110) | |||||||
---|---|---|---|---|---|---|---|---|
Risk Factor | N (%) (n=76) | 5-Year Cumulative Probability Failure (%) | P * | HR; 95% CI | N (%) (n=110) | 5-Year Cumulative Probability Failure (%) | P * | HR; 95% CI |
Sex | 0.39 | 0.55 | ||||||
Male | 41 (54) | 39 | 0.73; 0.34–1.54 | 52 (47) | 37 | 0.83; 0.45–1.56 | ||
Female | 35 (46) | 37 | 58 (53) | 41 | ||||
Age (y) | 0.17 | 0.009 | ||||||
0-5 | 37 (49) | 43 | 0.38; 0.15–0.99† | 53 (48) | 45 | 0.25; 0.11–0.55† | ||
6-10 | 16 (21) | 20 | 2.80; 0.90–8.70‡ | 25 (23) | 13 | 5.05; 1.95–13.08‡ | ||
11+ | 23 (30) | 49 | 1.23; 0.54–2.97§ | 32 (29) | 56 | 1.48; 0.73–3.01§ | ||
Ethnicity | 0.20 | 0.14 | ||||||
Caucasian | 52 (68) | 31 | 1.62; 0.76–3.76 | 74 (67) | 35 | 1.59; 0.82–3.09 | ||
Non-Caucasian | 24 (32) | 47 | 36 (33) | 47 | ||||
Prior glaucoma surgeries | 0.18 | 0.01 | ||||||
None | 31 (41) | 28 | 1.69; 0.80–3.55 | 46 (42) | 25 | 2.41; 1.29–4.49 | ||
1 or more | 45 (59) | 45 | 64 (58) | 49 | ||||
Preoperative IOP (mm Hg) | 0.14 | 0.53 | ||||||
0-20 | 24 (32) | 55 | 0.42; 0.18–1.01∥ | 29 (26) | 52 | 0.70; 0.33–1.46∥ | ||
21-30 | 29 (38) | 31 | 0.78; 0.28–2.18¶ | 48 (44) | 36 | 0.92; 0.42–2.04¶ | ||
31+ | 23 (30) | 28 | 0.57; 0.24–1.37# | 33 (30) | 29 | 0.66; 0.29–1.47# | ||
Preoperative medications | 0.44 | 0.55 | ||||||
0-2 | 22 (29) | 47 | 0.71; 0.30–1.68 | 31 (28) | 49 | 0.82; 0.40–1.66 | ||
3+ | 54 (71) | 35 | 79 (72) | 36 | ||||
Procedure | 0.45 | 0.79 | ||||||
Single procedure | 62 (82) | 39 | 1.57; 0.57–4.33 | 88 (79) | 39 | 1.12; 0.51–2.46 | ||
Staged procedure | 14 (18) | 43 | 23 (21) | 40 | ||||
Concurrent procedure | 0.45 | 0.76 | ||||||
Yes | 37 (49) | 41 | 0.75; 0.36–1.58 | 54 (49) | 39 | 0.91; 0.49–1.69 | ||
No | 39 (51) | 33 | 56 (51) | 38 | ||||
Type of glaucoma | 0.32 | 0.32 | ||||||
Primary | 21 (28) | 30 | 1.48; 0.64–3.40 | 34 (31) | 34 | 1.38; 0.70–2.70 | ||
Secondary | 55 (72) | 41 | 76 (69) | 41 |
Statistically significant P<0.05 values are in bold.
P-value for Log-rank (Mantel Cox) test for 2 variables or for Log-rank for trend test for 3 variables.
Age 0 to 5 versus 6 to 10.
Age 6 to 10 versus 11+.
Age 0 to 5 versus 11+.
IOP 0 to 20 versus 21 to 30.
IOP 21 to 30 versus 31+.
IOP 0 to 20 versus 31+.
CI indicates confidence interval; HR, hazard ratio; IOP, intraocular pressure.